Thio-Maltopentaose

Star0

DB01719ExperimentalSmall molecule

Thio-Maltopentaose: Overview.

Formula / weight: C₃₀H₅₂O₂₃S₃ · 876.915 g/mol (avg)

Resolves to

Compound

PubChem449625

Structure

InChIKeyHQMKYAZGNUQLJB-DCFYERRSSA-NSMILES

[H][C@]1(S)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]5([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O

Targets

P30920Cyclomaltodextrin glucanotransferase

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Thio-Maltopentaose, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account